abstract |
The present invention provides compounds of structural formula (I) wherein X, Y, R 1 , R 2 and R 2 are as defined above. The compounds of the present invention are modulators, particularly antagonists, of the activity of the chemokine CCR5 receptor. CCR5 receptor modulators may be useful in the treatment of various inflammatory diseases and conditions and in the treatment of HIV and genetically related retrovirus infections. |